Elucidating novel disease mechanisms in severe asthma

- Kim, Richard Y., Rae, Brittany, Neal, Rachel, Donovan, Chantal, Pinkerton, James, Balachandran, Lohis, Starkey, Malcolm R., Knight, Darryl A., Horvat, Jay C., Hansbro, Philip M.

PD-L1 promotes early-life chlamydia respiratory infection-induced severe allergic airway disease

- Starkey, Malcolm R., Nguyen, Duc H., Brown, Alexandra C., Essilfie, Ama-Tawiah, Kim, Richard Y., Yagita, Hideo, Horvat, Jay C., Hansbro, Philip M.

The MIF antagonist ISO-1 attenuates corticosteroid-insensitive inflammation and airways hyperresponsiveness in an ozone-induced model of COPD

- Russell, Kirsty E., Chung, Kian Fan, Starkey, Malcolm R., Hansbro, Philip M., Adcock, Ian M., Wiegman, Coen H., Clarke, Colin J., Durham, Andrew L., Mallia, Patrick, Footit, Joseph, Johnston, Sebastian L., Barnes, Peter J., Hall, Simon R., Simpson, Karen D.

TRAIL deficiency and PP2A activation with salmeterol ameliorates egg allergen-driven eosinophilic esophagitis

- Sokulsky, Leon A., Collison, Adam M., Nightingale, Scott, Le Fevre, Anna, Percival, Elizabeth, Starkey, Malcolm R., Hansbro, Philip M., Foster, Paul S., Mattes, Joerg

Macrolide therapy suppresses key features of experimental steroid-sensitive and steroid-insensitive asthma

- Essilfie, Ama-Tawiah, Horvat, Jay C., Hansbro, Philip M., Kim, Richard Y., Mayall, Jemma R., Pinkerton, James W., Beckett, Emma L., Starkey, Malcolm R., Simpson, Jodie L., Foster, Paul S., Gibson, Peter G.

Targeting PI3K-p110α suppresses influenza virus infection in chronic obstructive pulmonary disease

- Hsu, Alan Chen-Yu, Starkey, Malcolm R., Wark, Peter A., Hansbro, Philip M., Hanish, Irwan, Parsons, Kristy, Haw, Tatt Jhong, Howland, Linda J., Barr, Ian, Mahony, James B., Foster, Paul S., Knight, Darryl A.

Pulmonary immunity during respiratory infections in early life and the development of severe asthma

- Hansbro, Philip M., Starkey, Malcolm R., Mattes, Joerg, Horvat, Jay C.

Programming of the lung in early life by bacterial infections predisposes to chronic respiratory disease

- Starkey, Malcolm R., Nguyen, Duc H., Kim, Richard Y., Nair, Prema M., Brown , Alexandra C., Essifie, Ama-Tawiah, Horvat, Jay C., Hansbro, Philip M.

Th2 cytokine antagonists: potential treatments for severe asthma

- Hansbro, Philip M., Scott, Grace V., Foster, Paul S., Essilfie, Ama-Tawiah, Kim, Richard Y., Starkey, Malcolm R., Nguyen, Duc H., Allen, Paul D., Kaiko, Gerard E., Yang, Ming, Horvat, Jay C.

Chlamydia muridarum lung infection in infants alters hematopoietic cells to promote allergic airway disease in mice

- Starkey, Malcolm R., Kim, Richard Y., Horvat, Jay C., Hansbro, Philip M., Idzco, Marco, Beckett, Emma L., Schilter, Heidi C., Shim, Doris, Essilfie, Ama-Tawiah, Nguyen, Duc H., Beagley, Kenneth W., Joerg, Mattes, Mackay, Charles R.

TLR2, but not TLR4, is required for effective host defence against chlamydia respiratory tract infection in early life

- Beckett, Emma L., Phipps, Simon, Starkey, Malcolm R., Horvat, Jay C., Beagley, Kenneth W., Foster, Paul S., Hansbro, Phillip M.

Chlamydial respiratory infection during allergen sensitization drives neutrophilic allergic airways disease

- Horvat, Jay C., Starkey, Malcolm R., Kim, Richard Y., Beagley, Kenneth W., Preston, Julie A., Gibson, Peter G., Foster, Paul S., Hansbro, Philip M.

Early-life chlamydial lung infection enhances allergic airways disease through age-dependent differences in immunopathology

- Horvat, Jay C., Starkey, Malcolm R., Kim, Richard Y., Phipps, Simon, Gibson, Peter G., Beagley, Kenneth W., Foster, Paul S., Hansbro, Philip M.